UroGen Pharma Ltd. ($URGN)
Filing Information
| Accession Number | 0001437749-26-003040 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,373
Total Value
$145,174.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Ordinary Shares | โ | Feb 3, 2026 | Sale | 1,844 | $19.69 | $36,308.36 | 150,514 | Direct | โ | View Details | |
Chief Medical Officer | Ordinary Shares | โ | Feb 3, 2026 | Sale | 1,843 | $19.69 | $36,288.67 | 148,671 | Direct | โ | View Details | |
Chief Medical Officer | Ordinary Shares | โ | Feb 3, 2026 | Sale | 3,686 | $19.69 | $72,577.34 | 144,985 | Direct | โ | View Details |